Considering the case for an antidepressant drug trial involving temporary deception: A qualitative enquiry of potential participants

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Dowrick, Christopher F ^a   Hughes, John G ^a   Hiscock, Julia J ^b   Wigglesworth, Mark ^c   Walley, Thomas J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Aintree Park Group Practice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; DATA ANALYSIS; DEPRESSION; GENERAL PRACTITIONER; HUMAN; MEDICAL ETHICS; METHODOLOGY; PSYCHIATRIST; QUALITATIVE RESEARCH; RANDOMIZATION; ADULT; CONTROLLED CLINICAL TRIAL; ETHICS; FEMALE; GENERAL PRACTICE; HEALTH PERSONNEL ATTITUDE; INFORMATION PROCESSING; INTERVIEW; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL; RECUMBENCY; UNITED KINGDOM;

ADULT; ANTIDEPRESSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; DECEPTION; DEPRESSIVE DISORDER; ENGLAND; FAMILY PRACTICE; FEMALE; FOCUS GROUPS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PLACEBOS; PSYCHIATRY; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIALS;

EID: 34248643732     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-64     Document Type: Article

References (20)

1. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. IM Anderson DJ Nutt JF Deakin, J Psychopharmacol 2000 14 3 20 10757248
2. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. CJ Whittington T Kendall P Fonagy D Cottrell A Cotgrove E Boddington, Lancet 2004 363 1341 5 10.1016/S0140-6736(04)16043-1 15110490
3. Consensus Development Panel. National Depressive and Manic-Depressive Association Consensus Statement on the use of placebo in clinical trials of mood disorders. D Charney C Nemeroff L Lewis SK Laden JM Gorman EM Laska M Borenstein CL Bowden A Caplan GJ Emslie DL Evans B Geller LE Grabowski J Herson NH Kalin PE Keck Jr I Kirsch KR Krishnan DJ Kupfer RW Makuch FG Miller H Pardes R Post MM Reynolds L Roberts JF Rosenbaum DL Rosenstein DR Rubinow AJ Rush ND Ryan GS Sachs AF Schatzberg S Solomon, Arch Gen Psychiatry 2002 59 262 70 10.1001/archpsyc.59.3.262 11879164
4. Placebo in clinical trials for depression: complexity and necessity. D Kupfer E Frank, JAMA 2002 287 1853 4 10.1001/jama.287.14.1853 11939872
5. Placebo response in studies of major depression. BT Walsh SN Seidman R Sysko M Gould, JAMA 2002 287 1840 7 10.1001/jama.287.14.1840 11939870
6. The Emperor's New Drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. I Kirsch TJ Moore A Scoboria SS Nicholls, Prevention and Treatment 2002 5 Article 23
7. Are placebo controls necessary to test new antidepressants and anxiolytics? A Khan S Khan WA Brown, Int J Neuropsychopharmacol 2002 3 193 197 10.1017/S1461145702002912
8. How sound is the double-blind design for evaluating psychotropic drugs. S Fisher RP Greenberg, J Nerv Ment Dis 1993 181 345 50 10.1097/00005053- 199306000-00002 8501455
9. Patients' beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression. M Sullivan W Katon J Russo E Frank JE Barrett TE Oxman JW Williams Jr, J Am Board Fam Pract 2003 16 22 31 12583647
10. Are drug and placebo effects in depression additive? I Kirsch, Biol Psychiatry 2000 47 733 5 10.1016/S0006-3223(00)00832-5 10773181
11. How the doctor's words affect the patient's brain. F Benedetti, Eval Health Prof 2002 25 369 86 10.1177/0163278702238051 12449081
12. Cognitive processes in alcohol use: Expectancy and the balanced placebo design. GA Marlatt DJ Rohsenow, Advances in substance abuse: Behavioural and Biological Research Greenwich, CT: JAI Press, Mello NK, 1980 159 199
13. Does expectancy affect alcohol absorption? S Cole-Harding VJ Michels, Addict Behav 2007 32 1 194 8 Epub 2006 May 18 10.1016/j.addbeh.2006.03.042 16713125
14. The effects of a caffeine placebo and suggestion on blood pressure, heart rate, well-being and cognitive performance. H Walach S Schmidt T Dirhold S Nosch, Int J Psychophysiol 2002 43 247 60 10.1016/S0167-8760(01)00188-X 11850090
15. Deception in the pursuit of science. D Wendler FG Miller, Arch Int Med 2004 164 597 600 10.1001/archinte.164.6.597
16. Home Evaluation of Stroke Induced Aid Study Group. Patients' evaluation of informed consent to postponed information: cohort study. H Boter JJ van Delden RJ de Haan GJ Rinkel, BMJ 2004 329 86 15210571 10.1136/bmj.38041.636250. EE
17. MQ Patton, Qualitative Research and Evaluation Methods Thousand Oaks, CA: Sage 2002
18. J Ritchie J Lewis, Qualitative Research Practice London: Sage 2003
19. Deception in research on the placebo effect. FG Miller D Wendler LC Swartzman, PLoS Med Epub 2005 Sep 6
20. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. L Colloca L Lopiano M Lanotte F Benedetti, Lancet Neurol 2004 3 679 84 10.1016/S1474-4422(04)00908-1 15488461